Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Revenue

In the fiscal year ending March 31, 2026, Ipca Laboratories had annual revenue of 98.21B INR with 9.84% growth. Ipca Laboratories had revenue of 24.82B in the quarter ending March 31, 2026, with 10.40% growth.

• Revenue: 98.21B
• Revenue Growth: +9.84%
• P/S Ratio: 3.94
• Revenue / Employee: 5.85M
• Employees: 16,778
• Market Cap: 386.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	98.21B	8.80B	9.84%
Mar 31, 2025	89.41B	12.35B	16.03%
Mar 31, 2024	77.06B	14.58B	23.33%
Mar 31, 2023	62.48B	4.18B	7.16%
Mar 31, 2022	58.31B	4.10B	7.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error